An interesting discussion from @dylanhmorris a few weeks ago, as the corollary recommendation matches the structure of global vaccine supply *and* provides increased protection (For example: AZ prime + mRNA booster). https://twitter.com/dylanhmorris/status/1399813827093540867 …
-
-
This is the question being pondered:https://twitter.com/michaelzlin/status/1407060027781832707 …
Show this threadThanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Is it 12% breakthrough infections (delta) w mRNA vaccines? Or is it 21% per this recent study: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01358-1/fulltext … Pfizer 92% for alpha, 79% for delta. AstraZeneca 73% for alpha, 60% for delta
-
Ah, difference is the 12% # is for symptomatic disease. The 21% is for breakthrough infection. So we still don't know # for J&J breakthrough infection?
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.